Company intelligence / Profile preview

Corealis Pharma

Laval, Quebec, Canadacorealispharma.com ↗

Ownership: Private
Employees: ~40
Development stage: Other

Overview

No proprietary clinical results; over 200 drug products developed and more than 65 phase I/II clinical trial materials manufactured for clients since inception. Provides formulation development and manufacturing services supporting regulatory filings globally.

Modalities: Small moleculeOral solid dosage forms (tablets, capsules, granules)
Industry: Contract Manufacturing Organization

Partnerships

Archimed Group (investment partner)Caisse de dépôt et placement du Québec / CDPQ (investment partner)

Beyond the preview

Go deeper on Corealis Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corealis Pharma.

Explore the full profile